Ownership as of June 30, 2021. Ten largest shareholders.
| Name | Series A shares | Series B shares | Share capital % | Voting rights % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENTS AB | 377736 | 410478 | 7.02 | 28.63 |
| SIX SIS AG, W8IMY | 0 | 1183542 | 10.54 | 8.09 |
| FJÄRDE AP-FONDEN | 0 | 1120000 | 9.98 | 7.66 |
| SWEDBANK ROBUR NY TEKNIK BTI | 0 | 579172 | 5.16 | 3.96 |
| AMF AKTIEFOND SMÅBOLAG | 0 | 501585 | 4.47 | 3.43 |
| TREDJE AP-FONDEN | 0 | 438565 | 3.91 | 3.00 |
| CBNY-NORGES BANK | 0 | 325620 | 2.90 | 2.23 |
| UNIONEN | 0 | 322196 | 2.87 | 2.20 |
| DANGOOR, DAVID | 0 | 306421 | 2.73 | 2.10 |
| ÅLANDSBANKEN I ÄGARES STÄLLE | 0 | 258709 | 2.30 | 1.77 |
| Sub-total | 377736 | 5446288 | 51.88 | 63.07 |
| Other shareholders | 0 | 5402160 | 48.12 | 36.93 |
| Total | 377736 | 10848448 | 100.00 | 100.00 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.